Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 5
Submit an article Journal homepage
25
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Influence of cladribine alone and in combinaton with cyclophosphamide or cyclophosphamide and mitoxantrone on bone marrow angiogenesis in chronic lymphocytic leukemia

Anna Szmigielska-Kapłon Department of Hematology, Medical University in Lodz, Copernicus Hospital, Lodz, Poland
,
Dorota Jesionek-Kupnicka Department of Histopathology, Institute of Oncology, Medical University in Lodz, Copernicus Hospital, Lodz, Poland
,
Joanna Góra-Tybor Department of Hematology, Medical University in Lodz, Copernicus Hospital, Lodz, Poland
,
Jerzy Z. Błoński Department of Hematology, Medical University in Lodz, Copernicus Hospital, Lodz, Poland
,
Ewa Lech-Marańda Department of Hematology, Medical University in Lodz, Copernicus Hospital, Lodz, Poland
,
Radzisław Kordek Department of Histopathology, Institute of Oncology, Medical University in Lodz, Copernicus Hospital, Lodz, Poland
,
Marek Kasznicki Department of Hematology, Medical University in Lodz, Copernicus Hospital, Lodz, Poland
&
Professor Tadeusz Robak Department of Hematology, Medical University in Lodz, Copernicus Hospital, Lodz, PolandCorrespondence[email protected]
, MD, PhD show all
Pages 1042-1044 | Received 24 Nov 2006, Accepted 23 Jan 2007, Published online: 01 Jul 2009

References

  • Tung-Ping Poon R, Fan S T, Wong J. Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001; 19: 1207–1225
  • Mangi M H, Newland A C. Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol 2000; 111: 43–51
  • Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–2245
  • Molica S, Vacca A, Ribatti D, CuneoA, Cavazzini F, Levato D, et al. Prognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemia. Blood 2002; 100: 3344–3351
  • Góra-Tybor J, Błoński J Z, Robak T. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia. Mediators Inflamm 2003; 12: 167–171
  • Molica S, Vitelli G, Levato D, Gandolfo G M, Liso V. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukemia. Br J Haematol 1999; 107: 605–610
  • Kini A R, Kay N E, Peterson L C. Increased bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414–1418
  • Cheson B D, Bennett J M, Grever M, Kay N, Keating M J, O'Brien S, Rai K R. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
  • Rai K R, Sawitsky A, Cronkite E P, Chanana A D, Levy R N, Pasternack B S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
  • Kay N E, Bone N D, Tschumper R C, Howell K H, Geyer S M, Dewald G W, et al. B-CLL cells are capable of synthesis and secretion of both pro- and antiangiogenic molecules. Leukemia 2002; 16: 911–919
  • Wołowiec D, Dybko J, Wrobel T, Urbaniak-Kujda D, Jazwiec B, Tomaszewska-Toporska B, et al. Circulating sCD138 and some angiogenesis involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia. Mediators Inflamm 2006; 3: 42394
  • Wolowiec D, Wozniak Z, Potoczek S, Ganczarski G, Wrobel T, Kuliczkowski K, et al. Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia. Anal Qant Cytol Histol 2004; 26(5)263–270
  • Robak T. Therapy of chronic lymphocytic leukemia with purine nucleoside analogues. Drugs Aging 2006; 22: 983–1012
  • Molica S, Vacca A, Tucci L, Ribatti D. Reversed bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy. Hematologica/Hematol J 2005; 90: 698–699
  • Gora-Tybor J, Blonski J Z, Robak T. Cladribine decreases the level of angiogenic factors in patients with chronic lymphocytic leukemia. Neoplasma 2002; 49: 145–148

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.